New Hampshire HB1809: (New Title) establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin

Sponsors

• Buzz Scherr (D, 26) · primary sponsor
• Carol McGuire (R, 27)
• Erica Layon (R, 13)
• Jennifer Mandelbaum (D, 21)
• Sabourin dit Choinière, Matt (R, 30)
• Donovan Fenton (D, 10)

Latest actions

1. May 5, 2026: Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/07/2026; SJ 11
2. April 23, 2026: Committee Report: Inexpedient to Legislate, 05/07/2026, Vote 4-0, CC; SC 17
3. April 1, 2026: Hearing: 04/08/2026, Room 100, SH, 09:45 am; SC 13
4. March 30, 2026: Introduced 03/26/2026 and Referred to Health and Human Services; SJ 7
5. March 26, 2026: Ought to Pass with Amendment 2026-1201h: MA VV 03/26/2026 HJ 9
6. March 26, 2026: Amendment # 2026-1201h (NT): AA DV 248-101 03/26/2026 HJ 9
7. March 26, 2026: Inexpedient to Legislate: MF DV 127-222 03/26/2026 HJ 9
8. March 19, 2026: Minority Committee Report: Ought to Pass with Amendment # 2026-1201h (NT)
9. March 19, 2026: Majority Committee Report: Inexpedient to Legislate 03/17/2026 (Vote 13-11; RC)
10. March 13, 2026: Executive Session: 03/17/2026 10:00 am GP 230

Common questions

What is HB1809?

HB1809 is a bill in the New Hampshire Legislature (2025 Regular Session): (New Title) establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin.

What does HB1809 do?

(New Title) establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

What is the status of HB1809?

Failed as of May 5, 2026. Latest action: Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/07/2026; SJ 11 (May 5, 2026).

Who sponsored HB1809?

Buzz Scherr (D, 26), with 5 co-sponsors.

Where is the official record for HB1809?

On the New Hampshire Legislature website: https://gc.nh.gov/bill_status/legacy/bs2016/bill_docket_report.aspx?lsr=2497&sy=2026